Analysts have revised their price target for PCBL Chemical downward from ₹465.90 to ₹444.30. Updated projections indicate slightly higher growth expectations and improved profit margins. However, there is a more cautious valuation outlook overall.
What's in the News
- The board meeting is scheduled for October 17, 2025, to review and approve the unaudited financial results for the quarter and half-year ending September 30, 2025. The board will also consider the declaration of an interim dividend and its record date (Board Meeting).
- PCBL Chemical Limited, Firstsource Solutions Limited, and RP Sanjiv Goenka Group held an Analyst/Investor Day (Analyst/Investor Day).
Valuation Changes
- Consensus Analyst Price Target has fallen from ₹465.90 to ₹444.30, reflecting a more conservative outlook.
- Discount Rate has increased slightly from 14.57% to 14.67%.
- Revenue Growth projections have increased from 12.31% to 13.55%.
- Net Profit Margin estimates have increased modestly from 8.79% to 9.31%.
- Future P/E Ratio has declined from 25.39x to 22.19x, indicating reduced valuation expectations.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.